Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)

Shiue Wei Lai; Oluwaseun Adebayo Bamodu; Wen Chiuan Tsai; Yi Ming Chang; Wei Hwa Lee; Chi Tai Yeh; Tsu Yi Chao

doi:10.1007/s10585-018-9949-z

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)

Shiue Wei Lai, Oluwaseun Adebayo Bamodu, Wen Chiuan Tsai, Yi Ming Chang, Wei Hwa Lee, Chi Tai Yeh, Tsu Yi Chao

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

2 引文斯高帕斯（Scopus）

摘要

In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction.

原文	英語
頁（從 - 到）	67
頁數	1
期刊	Clinical and Experimental Metastasis
卷	36
發行號	1
DOIs	https://doi.org/10.1007/s10585-018-9949-z
出版狀態	已發佈 - 2月 15 2019

ASJC Scopus subject areas

腫瘤科
癌症研究

UN SDG

此研究成果有助於以下永續發展目標

存取文件

10.1007/s10585-018-9949-z

其它文件與鏈接

Link to publication in Scopus

指紋

深入研究「Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)」主題。共同形成了獨特的指紋。

引用此

Lai, S. W., Bamodu, O. A., Tsai, W. C., Chang, Y. M., Lee, W. H., Yeh, C. T., & Chao, T. Y. (2019). Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5). Clinical and Experimental Metastasis, 36(1), 67. https://doi.org/10.1007/s10585-018-9949-z

Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5). / Lai, Shiue Wei; Bamodu, Oluwaseun Adebayo; Tsai, Wen Chiuan 等.
於: Clinical and Experimental Metastasis, 卷 36, 編號 1, 15.02.2019, p. 67.

研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

Lai, SW, Bamodu, OA, Tsai, WC, Chang, YM, Lee, WH , Yeh, CT & Chao, TY 2019, 'Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)', Clinical and Experimental Metastasis, 卷 36, 編號 1, 頁 67. https://doi.org/10.1007/s10585-018-9949-z

Lai SW, Bamodu OA, Tsai WC, Chang YM, Lee WH , Yeh CT 等. Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5). Clinical and Experimental Metastasis. 2019 2月 15;36(1):67. doi: 10.1007/s10585-018-9949-z

Lai, Shiue Wei ; Bamodu, Oluwaseun Adebayo ; Tsai, Wen Chiuan 等. / Correction to : The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5). 於: Clinical and Experimental Metastasis. 2019 ; 卷 36, 編號 1. 頁 67.

@article{2554a1c5f1b448e39bc476173fbed5c4,

title = "Correction to: The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)",

abstract = "In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction.",

author = "Lai, {Shiue Wei} and Bamodu, {Oluwaseun Adebayo} and Tsai, {Wen Chiuan} and Chang, {Yi Ming} and Lee, {Wei Hwa} and Yeh, {Chi Tai} and Chao, {Tsu Yi}",

note = "Publisher Copyright: {\textcopyright} 2019, Springer Nature B.V.",

year = "2019",

month = feb,

day = "15",

doi = "10.1007/s10585-018-9949-z",

language = "English",

volume = "36",

pages = "67",

journal = "Clinical and Experimental Metastasis",

issn = "0262-0898",

publisher = "Springer Netherlands",

number = "1",

}

TY - JOUR

T1 - Correction to

T2 - The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity (Clinical & Experimental Metastasis, (2018), 35, 7, (663-677), 10.1007/s10585-018-9919-5)

AU - Lai, Shiue Wei

AU - Bamodu, Oluwaseun Adebayo

AU - Tsai, Wen Chiuan

AU - Chang, Yi Ming

AU - Lee, Wei Hwa

AU - Yeh, Chi Tai

AU - Chao, Tsu Yi

PY - 2019/2/15

Y1 - 2019/2/15

N2 - In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction.

AB - In the original publication, the affiliations of authors were published incorrectly. The corrected affiliations are given in this Correction.

UR - http://www.scopus.com/inward/record.url?scp=85059576217&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059576217&partnerID=8YFLogxK

U2 - 10.1007/s10585-018-9949-z

DO - 10.1007/s10585-018-9949-z

M3 - Comment/debate

AN - SCOPUS:85059576217

SN - 0262-0898

VL - 36

SP - 67

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

IS - 1

ER -